RogerioLilenbaumMD

Oncology • Jupiter, FL

Chief Physician Executive

Join to view full profile

Dr. Lilenbaum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lilenbaum's full profile

Already have an account?

Office
1210 S. Dixie Hwy,
Jupiter, FL 33458
Is this information wrong?

Summary

Dr. Rogerio Lilenbaum is the Chief Physician Executive of Jupiter Medical Center in Jupiter, FL. He received his medical degree from the Federal University of Rio de Janeiro and completed his training at Washington University in St Louis and at the University of California San Diego. He specializes in thoracic oncology.

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1991 - 1992
Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 1986

Certifications & Licensure

CA State Medical License 1992 - Present
FL State Medical License 1996 - 2025
AZ State Medical License 2020 - 2024
CT State Medical License 2013 - 2020
MD State Medical License 1995 - 1998

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2014
America's Top Doctors Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top Doctors:South Florida Castle Connolly, 2012
Gulfstream FL-Broward Castle Connolly, 2012
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Fellow (FACP) American College of Physicians, 2002
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer Start of enrollment: 1997 Oct 01
Completed
Phase 3
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma Start of enrollment: 1984 Jun 01
Active, not recruiting
Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2005 Jul 01
Completed
Phase 2
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2005 May 01
Completed
Phase 3
Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer Start of enrollment: 2004 Jun 01
Completed
Phase 2
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
Active, not recruiting
Phase 3
L-Arginine Supplements in Treating Women Who Are Cancer Survivors Start of enrollment: 2007 May 01
Completed
Not Applicable
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery Start of enrollment: 2008 Mar 01
Completed
Phase 2
G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer Start of enrollment: 2008 Jan 01
Completed
Phase 2
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Start of enrollment: 2008 May 15
Active, not recruiting
Phase 3
Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2003 Sep 01
Completed
Phase 2
Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Start of enrollment: 2008 Apr 15
Completed
Phase 2
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15
Completed
Phase 3
Trial of Poor Performance Status Patients (ToPPS) Start of enrollment: 2009 Jun 01
Completed
Phase 2
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
MK-3475 in Melanoma and NSCLC Patients With Brain Metastases Start of enrollment: 2014 Mar 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

34 citations
Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR-Mutant Non-Small-Cell Lung Cancer: Final Results From SWOG S1403.
Sarah B. Goldberg, Mary W. Redman, Rogerio Lilenbaum, Katerina Politi, Thomas E. Stinchcombe, Leora Horn, Everett H. Chen, Sandeep H. Mashru, Scott N. Gettinger, Mary ...> ;Journal of Clinical Oncology. 2020 Oct 6
277 citations
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.
Sarah B. Goldberg, Kurt A. Schalper, Scott N. Gettinger, Amit Mahajan, Roy S. Herbst, Anne C. Chiang, Rogerio Lilenbaum, Frederick H. Wilson, Sacit Bulent Omay, James ...> ;The Lancet. Oncology. 2020 May 1
9 citations
Measuring the Impact of Academic Cancer Network Development on Clinical Integration, Quality of Care, and Patient Satisfaction
Anne C. Chiang, Jessica Lake, Naralys Sinanis, Debra S. Brandt, Jane Kanowitz, Wajih Zaheer Kidwai, Jeremy S. Kortmansky, Johanna LaSala, Jeffrey Orell, Kert D. Sabbat...> ;Journal of Oncology Practice. 2018 Dec 11
7 citations
Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospect...
Josephine Feliciano, Jennifer Le-Rademacher, Ajeet Gajra, Martin J. Edelman, Tyler Zemla, Ryan McMurray, Hongbin Chen, Arti Hurria, Hyman B. Muss, Harvey J. Cohen, Rog...> ;Journal of Geriatric Oncology. 2018 Sep 1
365 citations
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018
David S. Ettinger, Dara L. Aisner, Douglas E. Wood, Wallace Akerley, Jessica Bauman, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D'Amico, Thomas J. Dilling, Michael C....> ;Journal of the National Comprehensive Cancer Network. 2018 Jul 1
17 citations
Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A1...
Ajeet Gajra, Tyler Zemla, Aminah Jatoi, Josephine Feliciano, Melisa L. Wong, Hongbin Chen, Ronald J. Maggiore, Ryan McMurray, Arti Hurria, Hyman B. Muss, Harvey J. Coh...> ;Journal of Thoracic Oncology. 2018 Jul 1
76 citations
Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non–Small Cell Lung Cancer
Scott N. Gettinger, Anna Wurtz, Sarah B. Goldberg, David L. Rimm, Kurt A. Schalper, Susan M. Kaech, Paula Kavathas, Anne C. Chiang, Rogerio Lilenbaum, Daniel Zelterman...> ;Journal of Thoracic Oncology. 2018 Jun 1
12 citations
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.
David E. Gerber, Mark A. Socinski, Joel W. Neal, Heather A. Wakelee, Keisuke Shirai, Lecia V. Sequist, Rachel P. Rosovsky, Rogerio Lilenbaum, Bruno R. Bastos, Chao Hua...> ;Lung Cancer. 2018 Mar 1
13 citations
Development of Imminent Mortality Predictor for Advanced Cancer (IMPAC), a Tool to Predict Short-Term Mortality in Hospitalized Patients With Advanced Cancer.
Kerin B. Adelson, Donald K. K. Lee, Salimah Velji, Junchao Ma, Susan K. Lipka, Joan M. Rimar, Peter Longley, Teresita Vega, Javier Perez-Irizarry, Edieal J. Pinker, Ro...> ;Journal of Oncology Practice. 2017 Dec 5
896 citations
Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica Bauman, Lucian R. Chirieac, Thomas A. D'Amico, Malcolm M. DeCamp, Thomas J. Dilling, Micha...> ;Journal of the National Comprehensive Cancer Network. 2017 Apr 1
9 citations
Preparing for Value-Based Payment: A Stepwise Approach for Cancer Centers.
Kerin B. Adelson, Salimah Velji, Kavita Patel, Basit Iqbal Chaudhry, Catherine A. Lyons, Rogerio Lilenbaum> ;Journal of Oncology Practice. 2016 Oct 23
9 citations
Optimizing Treatment Risk and Benefit for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Right Treatment for the Right Patient
Carolyn Jean Presley, Cary P. Gross, Rogerio Lilenbaum> ;Journal of Clinical Oncology. 2016 Sep 27
62 citations
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016
David S. Ettinger, Douglas E. Wood, Wallace Akerley, Lyudmila Bazhenova, Hossein Borghaei, D.R. Camidge, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Thom...> ;Journal of the National Comprehensive Cancer Network. 2016 Jul 1
9 citations
Assessing Clinical Trial-Associated Workload in Community-Based Research Programs Using the ASCO Clinical Trial Workload Assessment Tool
Marjorie J. Good, Patricia Hurley, Kaitlin M. Woo, Connie M. Szczepanek, Teresa L. Stewart, Nicholas Robert, Alan Lyss, Mithat Gonen, Rogerio Lilenbaum> ;Journal of Oncology Practice. 2016 Mar 22
332 citations
NCCN Guidelines ® Insights: Non-Small Cell Lung Cancer, Version 4.2016 Featured Updates to the NCCN Guidelines
David S. Ettinger, Douglas E. Wood, Wallace Akerley, Lyudmila Bazhenova, Hossein Borghaei, D.R. Camidge, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Thom...> ;Journal of the National Comprehensive Cancer Network. 2016 Mar 1
35 citations
Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer
Christopher D. Corso, Charles E. Rutter, Henry S. Park, Nataniel H. Lester-Coll, Anthony W. Kim, Lynn D. Wilson, Zain A. Husain, Rogerio Lilenbaum, James B. Yu, Roy H....> ;Journal of Clinical Oncology. 2015 Dec 20
11 citations
The Treatment of Advanced Lung Cancer in the Elderly: The Role of a Comprehensive Geriatric Assessment and Doublet Chemotherapy.
Carolyn J Presley, Rogerio Lilenbaum> ;Cancer Journal. 2015 Sep 1
35 citations
The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap.
David S. Klimstra, Himisha Beltran, Rogerio Lilenbaum, Emily K. Bergsland> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2015 May 14
451 citations
Non–Small Cell Lung Cancer, Version 6.2015
David S. Ettinger, Douglas E. Wood, Wallace Akerley, Lyudmila Bazhenova, Hossein Borghaei, D.R. Camidge, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd...> ;Journal of the National Comprehensive Cancer Network. 2015 May 1
55 citations
Treatment of Elderly Patients With Non-Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
Cesare Gridelli, Lodovico Balducci, Fortunato Ciardiello, Massimo Di Maio, Enriqueta Felip, Corey J. Langer, Rogerio Lilenbaum, Francesco Perrone, Suresh Senan, Filipp...> ;Clinical Lung Cancer. 2015 Sep 1
37 citations
A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (A...
Rogerio Lilenbaum, Michael A. Samuels, Xiaofei Wang, Feng Ming Kong, Pasi A. Jänne, Gregory A. Masters, Sreedhar Katragadda, Lydia Hodgson, Jeffrey A. Bogart, Jeffrey ...> ;Journal of Thoracic Oncology. 2015 Jan 1
27 citations
Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).
Elizabeth B. Lamont, Richard L. Schilsky, Yulei He, Hyman B. Muss, Harvey J. Cohen, Arti Hurria, Ashley Meilleur, Hedy L. Kindler, Alan P. Venook, Rogerio Lilenbaum, H...> ;Journal of the National Cancer Institute. 2015 Jan 1
136 citations
Non-small cell lung cancer, version 1.2015: Clinical practice guidelines in oncology
David S. Ettinger, Douglas E. Wood, Wallace Akerley, Lyudmila Bazhenova, Hossein Borghaei, D.R. Camidge, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd...> ;Journal of the National Comprehensive Cancer Network. 2014 Dec 1
1 citations
ASCO's Community Research Forum: addressing challenges of community-based research from the grass roots.
Nicholas J. Robert, Rogerio Lilenbaum, Patricia Hurley> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2014 May 15
315 citations
American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
Lee M. Ellis, David Bernstein, Emile E. Voest, Jordan Berlin, Daniel J. Sargent, Patricia Cortazar, Elizabeth Garrett-Mayer, Roy S. Herbst, Rogerio Lilenbaum, Camelia ...> ;Journal of Clinical Oncology. 2014 Apr 20
Join now to see all

Other

Systemic therapy for advanced non-small cell lung cancer in elderly patients and patients with a poor performance status
Lilenbaum RC
http://www.uptodate.com/contents/systemic-therapy-for-advanced-non-small-cell-lung-cancer-in-elderly
UpToDate, Wolters Kluwer Health - 2012-12-18
Advanced non-small cell lung cancer: Maintenance therapy after initial chemotherapy
Lilenbaum RC
http://www.uptodate.com/contents/advanced-non-small-cell-lung-cancer-maintenance-therapy-after-initi
UpToDate, Wolters Kluwer Health - 2013-01-10
Initial systemic chemotherapy for advanced non-small cell lung cancer without an epidermal growth factor receptor mutation or the ALK fusion oncogene
Lilenbaum RC
http://www.uptodate.com/contents/initial-systemic-chemotherapy-for-advanced-non-small-cell-lung-canc
UpToDate, Wolters Kluwer Health - 2013-02-12
Initial systemic therapy for advanced non-small cell lung cancer with a mutation in the epidermal growth factor receptor
Lilenbaum RC
http://www.uptodate.com/contents/initial-systemic-therapy-for-advanced-non-small-cell-lung-cancer-wi
UpToDate, Wolters Kluwer Health - 2013-03-20
Overview of the treatment of advanced non-small cell lung cancer
Lilenbaum RC
http://www.uptodate.com/contents/overview-of-the-treatment-of-advanced-non-small-cell-lung-cancer
UpToDate, Wolters Kluwer Health - 2013-02-13
Second-line therapy for patients with previously treated advanced non-small cell lung cancer
Lilenbaum RC
http://www.uptodate.com/contents/second-line-therapy-for-patients-with-previously-treated-advanced-n
UpToDate, Wolters Kluwer Health - 2013-01-10
Systemic therapy for poor performance status patients with advanced non-small cell lung cancer
Lilenbaum RC
http://www.uptodate.com/contents/systemic-therapy-for-poor-performance-status-patients-with-advanced
UpToDate, Wolters Kluwer Health - 2012-06-29
Join now to see all

Press Mentions

Jupiter Medical Center Targets Prostate Cancer with PSMA PET-CT ScansJanuary 11th, 2023
Anderson Family Cancer Institute Offering Next-Day Appointments, Cutting-Edge TreatmentsJanuary 1st, 2023
Managing Cancer Care During COVID-19: 4 Oncologists Weigh InJuly 22nd, 2020
Join now to see all